United States · FDA National Drug Code directory
FARXIGA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0310-6210_6ae68943-041a-4236-8f49-fb8f0edc38cf
- Product NDC
- 0310-6210
- Form
- TABLET, FILM COATED
- Composition / generic term
- DAPAGLIFLOZIN
- Labeler
- AstraZeneca Pharmaceuticals LP
- Marketing category
- NDA
- Marketing start / end (source format)
- 20080114
- Source listing expiry
- 20271231
Source-listed ingredients
- DAPAGLIFLOZIN PROPANEDIOL — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-6210-30) · 0310-6210-30
- 3 BLISTER PACK in 1 CARTON (0310-6210-39) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 0310-6210-39
- 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-6210-90) · 0310-6210-90
- 1 BLISTER PACK in 1 CARTON (0310-6210-95) / 7 TABLET, FILM COATED in 1 BLISTER PACK · 0310-6210-95
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →